SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926617-17-000023
Filing Date
2017-03-31
Accepted
2017-03-30 18:43:31
Documents
66
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K c617-20161231x10k.htm 10-K 2114544
2 EX-21.0 c617-20161231xex21_0.htm EX-21.0 7510
3 EX-23.1 c617-20161231xex23_1.htm EX-23.1 6197
4 EX-31.1 c617-20161231xex31_1.htm EX-31.1 20407
5 EX-31.2 c617-20161231xex31_2.htm EX-31.2 20732
6 EX-32.0 c617-20161231xex32_0.htm EX-32.0 12186
  Complete submission text file 0000926617-17-000023.txt   7116847

Data Files

Seq Description Document Type Size
7 EX-101.INS c617-20161231.xml EX-101.INS 1404398
8 EX-101.SCH c617-20161231.xsd EX-101.SCH 45085
9 EX-101.CAL c617-20161231_cal.xml EX-101.CAL 48206
10 EX-101.DEF c617-20161231_def.xml EX-101.DEF 163868
11 EX-101.LAB c617-20161231_lab.xml EX-101.LAB 400226
12 EX-101.PRE c617-20161231_pre.xml EX-101.PRE 346652
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34810 | Film No.: 17727425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances